GlassScriptPhysician profile
Brian M Shuch
NPI 1134370422
$165,501.07
in general payments reported to CMS, 2019-2025
19 companies · $5,012 in 2025
The $5,012 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $638 · 2021: $14K · 2022: $32K · 2023: $66K · 2024: $46K · 2025: $5,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Consulting Fee: $21K · Honoraria: $13K · Education: $7,000 · Food and Beverage: $2,153 · Gift: $36.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $37,598.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,425.00 |
| Consulting Fee | $21,488.15 |
| Honoraria | $13,000.00 |
| Education | $7,000.00 |
| Food and Beverage | $2,152.99 |
| Gift | $36.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $84,258.60 | 2021-2025 | Keytruda, Welireg |
| Telix Pharmaceuticals | $52,951.21 | 2022-2025 | Illuccix |
| Janssen Research & Development, LLC | $18,578.15 | 2021-2023 | |
| Histosonics, INC. | $2,771.87 | 2024-2025 | |
| Intuitive Surgical, INC. | $2,624.40 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,854.00 | 2019 | |
| Genentech, INC. | $1,050.00 | 2021 | |
| Aveo Pharmaceuticals, INC. | $302.78 | 2021-2024 | |
| Medtronic USA, INC. | $253.74 | 2019-2020 | |
| Procept Biorobotics Corporation | $205.42 | 2023 | Aquabeam Robotic System |
| Smith+Nephew, INC. | $144.01 | 2022 | |
| Boston Scientific Corporation | $134.05 | 2020-2021 | |
| Covidien LP | $94.23 | 2019 | |
| Abbvie INC. | $67.81 | 2023-2025 | Botox |
| C. R. Bard, INC. & Subsidiaries | $66.18 | 2024 | Bard Urinary Drainage Bag |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $60.74 | 2021-2023 | Tisseel |
| Astellas Pharma US INC | $40.28 | 2019 | |
| Pfizer INC. | $30.32 | 2022 | |
| Cook Medical LLC | $13.28 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shuch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.